BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1581003)

  • 1. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
    Dai YF; Qiu XF; Xue JL; Liu ZD
    Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
    Lu D; Qiu X; Zheng B; Qiu X; Xue J
    Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
    Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
    Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage I clinical trial of gene therapy for hemophilia B.
    Lu DR; Zhou JM; Zheng B; Qiu XF; Xue JL; Wang JM; Meng PL; Han FL; Ming BH; Wang XP
    Sci China B; 1993 Nov; 36(11):1342-51. PubMed ID: 8142023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term expression of human factor IX cDNA in rabbits.
    Zhou JM; Qiu XF; Lu DR; Lu JY; Xue JL
    Sci China B; 1993 Nov; 36(11):1333-41. PubMed ID: 8142022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
    Yao SN; Smith KJ; Kurachi K
    Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards gene therapy for hemophilia B.
    Anson DS; Hock RA; Austen D; Smith KJ; Brownlee GG; Verma IM; Miller AD
    Mol Biol Med; 1987 Feb; 4(1):11-20. PubMed ID: 3475525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards gene therapy for haemophilia B using primary human keratinocytes.
    Gerrard AJ; Hudson DL; Brownlee GG; Watt FM
    Nat Genet; 1993 Feb; 3(2):180-3. PubMed ID: 8499952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of retroviral and adeno-associated viral vectors designed to express human clotting factor IX.
    Chen L; Perlick H; Morgan RA
    Hum Gene Ther; 1997 Jan; 8(2):125-35. PubMed ID: 9017417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast transplantation in rats: transduction and function of foreign genes.
    Neuzil D; Holzman M; Rozga J; Levine J; Moscioni AD; Demetriou AA
    J Surg Res; 1993 Jun; 54(6):631-7. PubMed ID: 8412074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX].
    Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL
    Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increment of hFIX expression with endogenous intron 1 in vitro.
    Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
    Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
    Hou J; Wang J; Min B
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system.
    Wahlfors JJ; Morgan RA
    Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
    Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
    Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of glial cell line-derived neurotrophic factor recombinant retroviral vector and establishment of its packaging cell line PA317].
    Zhang W; Li B; Ren X
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Nov; 20(11):1119-23. PubMed ID: 17191581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retroviral-mediated high efficient in vitro expression of human coagulation factor VIII].
    Guo X; Wang H; Chu H; Wang X; Qu B; Li Z; Qi Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Sep; 21(9):457-9. PubMed ID: 11877017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.